Pelthos Therapeutics
Durham, North Carolina, United States · Biotechnology, Healthcare, Health Care
Pelthos Therapeutics Inc. was formerly known as Chromocell Therapeutics Corp. Pelthos Therapeutics specializes in developing treatments for molluscum contagiosum infections. The company is known for its FDA-approved drug ZELSUVMI, which is the first prescription treatment for home use. Pelthos is committed to advancing patient care through innovative therapeutic solutions. It operates as a subsidi
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Durham, North Carolina, United States
- Employees
- 83
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (PTHS)
- Website
- pelthos.com
- Company page
Recent activity at Pelthos Therapeutics
About Pelthos Therapeutics: questions and answers
What does Pelthos Therapeutics do?
Pelthos Therapeutics Inc. was formerly known as Chromocell Therapeutics Corp. Pelthos Therapeutics specializes in developing treatments for molluscum contagiosum infections. The company is known for its FDA-approved drug ZELSUVMI, which is the first prescription treatment for home use. Pelthos is committed to advancing patient care through innovative therapeutic solutions. It operates as a subsidi
Where is Pelthos Therapeutics headquartered?
Pelthos Therapeutics is headquartered in Durham, North Carolina, United States.
How many employees does Pelthos Therapeutics have?
Pelthos Therapeutics has about 83 employees.
What is the latest news on Pelthos Therapeutics?
On Oct 30, 2026, Pelthos to merge with Castle Creek Biosciences
Is Pelthos Therapeutics a public company?
Yes. Pelthos Therapeutics is publicly traded under the ticker PTHS.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy